BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci. 2002;963:13-20. [PMID: 12095924 DOI: 10.1111/j.1749-6632.2002.tb04090.x] [Cited by in Crossref: 183] [Cited by in F6Publishing: 188] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Vertemati M, Minola E, Goffredi M, Sabatella G, Gambacorta M, Vizzotto L. Computerized morphometry of the cirrhotic liver: Comparative analysis in primary biliary cirrhosis, alcoholic cirrhosis, and posthepatitic cirrhosis. Microsc Res Tech 2004;65:113-21. [DOI: 10.1002/jemt.20110] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
2 Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2003;7:401-11. [PMID: 12654567 DOI: 10.1016/s1091-255x(02)00161-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 Rastogi T, Hildesheim A, Sinha R. Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer 2004;4:909-17. [DOI: 10.1038/nrc1475] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
4 Ma CQ, Yang Y, Wang JM, Du GS, Shen Q, Liu Y, Zhang J, Hu JL, Zhu P, Qi WP, Qian YW, Fu Y. The aPKCι blocking agent ATM negatively regulates EMT and invasion of hepatocellular carcinoma. Cell Death Dis 2014;5:e1129. [PMID: 24651432 DOI: 10.1038/cddis.2014.91] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
5 Sorlini M, Benini F, Cravarezza P, Romanelli G. Hypoglycemia, an atypical early sign of hepatocellular carcinoma. J Gastrointest Cancer. 2010;41:209-211. [PMID: 20204540 DOI: 10.1007/s12029-010-9137-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
6 Venook AP, Papandreou C, Furuse J, Ladrón de Guevara L. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. The Oncologist 2010;15:5-13. [DOI: 10.1634/theoncologist.2010-s4-05] [Cited by in Crossref: 575] [Cited by in F6Publishing: 343] [Article Influence: 47.9] [Reference Citation Analysis]
7 Wang J, Xu L, Zeng W, Hu P, Zeng M, Rabkin SD, Liu R. Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta. Cancer Cell Int 2014;14:83. [PMID: 25360068 DOI: 10.1186/s12935-014-0083-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kim SU, Kim YR, Kim DY, Kim JK, Lee HW, Kim BK, Han KH, Chon CY, Moon YM, Ahn SH. Clinical Features and Treatment Outcome of Advanced Hepatocellular Carcinoma with Inferior Vena Caval Invasion or Atrial Tumor Thrombus. Korean J Hepatol 2007;13:387. [DOI: 10.3350/kjhep.2007.13.3.387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
9 Zhang X, Gao L, Liang X, Guo M, Wang R, Pan Y, Liu P, Zhang F, Guo C, Zhu F. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes. Liver Int. 2015;35:1087-1094. [PMID: 25047684 DOI: 10.1111/liv.12642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
10 de Carvalho LR, Borrego A, Jensen JR, Cabrera WHK, Santos AM, Ribeiro OG, Starobinas N, De Franco M, Dragani TA, Manenti G, Ibañez OCM. Genetic Predisposition to Hepatocarcinogenesis in Inbred and Outbred Mouse Lines Selected for High or Low Inflammatory Response. J Immunol Res 2019;2019:5298792. [PMID: 31049358 DOI: 10.1155/2019/5298792] [Reference Citation Analysis]
11 Massoud O, Charlton M. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clinics in Liver Disease 2018;22:201-11. [DOI: 10.1016/j.cld.2017.08.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
12 Mans DRA, Mohamedradja RN, Hoeblal ARD, Rampadarath R, Joe SSTA, Wong J, Ramautar P, Mahabier R, Vrede MA. Cancer Incidence in Suriname from 1980 through 2000 a Descriptive Study. Tumori 2003;89:368-76. [DOI: 10.1177/030089160308900404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Abdel Wahab AHA, El-Halawany MS, Emam AA, Elfiky A, Abd Elmageed ZY. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers 2017;22:621-8. [PMID: 27788588 DOI: 10.1080/1354750X.2016.1252966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
14 Wang X, Wang Y, Zhang Q, Zhuang H, Chen B. MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker. Med Sci Monit 2018;24:1759-67. [PMID: 29576605 DOI: 10.12659/msm.909012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300-4308. [PMID: 18666317 DOI: 10.3748/wjg.v14.i27.4300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Holub M, Stráníková A, Beran O, Arientová S, Bartoš O, Kondelková K, Plíšek S, Chalupa P. Chronic Hepatitis C Virus Infection Modulates the Transcriptional Profiles of CD4+ T Cells. Can J Infect Dis Med Microbiol 2021;2021:6689834. [PMID: 33777278 DOI: 10.1155/2021/6689834] [Reference Citation Analysis]
17 DesMeules M, Gold J, McDermott S, Cao Z, Payne J, Lafrance B, Vissandjée B, Kliewer E, Mao Y. Disparities in mortality patterns among Canadian immigrants and refugees, 1980-1998: results of a national cohort study. J Immigr Health 2005;7:221-32. [PMID: 19813288 DOI: 10.1007/s10903-005-5118-y] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
18 Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol 2015; 7(12): 1708-1717 [PMID: 26140091 DOI: 10.4254/wjh.v7.i12.1708] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
19 Xu P, Wu M, Chen H, Xu J, Wu M, Li M, Qian F, Xu J. Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells. Onco Targets Ther 2016;9:191-202. [PMID: 26811688 DOI: 10.2147/OTT.S91748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
20 Liu CL, Lim YP, Hu ML. Fucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells. Mar Drugs 2013;11:50-66. [PMID: 23299493 DOI: 10.3390/md11010050] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
21 Tu T, Budzinska MA, Maczurek AE, Cheng R, Di Bartolomeo A, Warner FJ, McCaughan GW, McLennan SV, Shackel NA. Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development. Int J Mol Sci. 2014;15:9422-9458. [PMID: 24871369 DOI: 10.3390/ijms15069422] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
22 Chen M, Huang JD, Hu L, Zheng BJ, Chen L, Tsang SL, Guan XY. Transgenic CHD1L expression in mouse induces spontaneous tumors. PLoS One. 2009;4:e6727. [PMID: 19701453 DOI: 10.1371/journal.pone.0006727] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
23 Pai A, Lin A. Chronic asymptomatic hepatitis B presenting with metastatic hepatocellular carcinoma. J Clin Oncol 2008;26:4209-11. [PMID: 18757338 DOI: 10.1200/JCO.2008.16.0523] [Reference Citation Analysis]
24 Shaker MK, Abdella HM, Khalifa MO, El Dorry AK. Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases. Liver Int. 2013;33:1601-1606. [PMID: 23714212 DOI: 10.1111/liv.12209] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
25 Soresi M, La Spada E, Giannitrapani L, Campagna E, Di Gesaro V, Granà W, Sandonato L, Brancatelli G, Rotolo G, Affronti A. Hepatocellular carcinoma: comparison of two different periods at the same center. Eur J Intern Med. 2010;21:127-130. [PMID: 20206885 DOI: 10.1016/j.ejim.2009.12.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
26 Nakatake R, Kaibori M, Nakamura Y, Tanaka Y, Matushima H, Okumura T, Murakami T, Ino Y, Todo T, Kon M. Third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice. Cancer Sci 2018;109:600-10. [PMID: 29288515 DOI: 10.1111/cas.13492] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
27 Lee KW, Lee HJ, Lee CY. Vitamins, Phytochemicals, Diets, and Their Implementation in Cancer Chemoprevention. Critical Reviews in Food Science and Nutrition 2004;44:437-52. [DOI: 10.1080/10408690490886674] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
28 Zheng B, Zhu YJ, Wang HY, Chen L. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci. 2017;60:575-584. [PMID: 28547581 DOI: 10.1007/s11427-016-9043-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
29 Abdel-Hamid NM. Recent insights on risk factors of hepatocellular carcinoma. World J Hepatol 2009; 1(1): 3-7 [PMID: 21160959 DOI: 10.4254/wjh.v1.i1.3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
30 Giannitrapani L, Ingrao S, Soresi M, Florena AM, La Spada E, Sandonato L, D'Alessandro N, Cervello M, Montalto G. Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . Ann N Y Acad Sci 2009;1155:293-9. [PMID: 19250220 DOI: 10.1111/j.1749-6632.2009.03698.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
31 Cheung CY, Lam MF, Chow KM, Lee W, Cheng YL, Yuen SK, Wong PN, Mo KL, Leung KT, Wong SH, Ho YW, Chau KF. Hepatocellular carcinoma after kidney transplantation: analysis of Hong Kong Renal Registry. Renal Failure 2014;36:865-9. [DOI: 10.3109/0886022x.2014.899879] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Badawy AA, El-hindawi A, Hammam O, Moussa M, Gabal S, Said N. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis. APMIS 2015;123:823-31. [DOI: 10.1111/apm.12431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
33 Trad D, Bibani N, Sabbah M, Elloumi H, Gargouri D, Ouakaa A, Kharrat J. Known, new and emerging risk factors of hepatocellular carcinoma (review). La Presse Médicale 2017;46:1000-7. [DOI: 10.1016/j.lpm.2017.09.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
34 Cavenaugh JS, Awi D, Mendy M, Hill AV, Whittle H, McConkey SJ. Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection. PLoS One 2011;6:e14626. [PMID: 21347224 DOI: 10.1371/journal.pone.0014626] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
35 McKeon D, Day A, Parmar J, Alexander G, Bilton D. Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis.J Cyst Fibros. 2004;3:193-195. [PMID: 15463908 DOI: 10.1016/j.jcf.2004.04.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
36 McCubrey JA, Steelman LS, Abrams SL, Chappell WH, Russo S, Ove R, Milella M, Tafuri A, Lunghi P, Bonati A. Emerging MEK inhibitors. Expert Opin Emerg Drugs. 2010;15:203-223. [PMID: 20151845 DOI: 10.1517/14728210903282760] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
37 Alves VA, Pinheiro C, Morais-Santos F, Felipe-Silva A, Longatto-Filho A, Baltazar F. Characterization of monocarboxylate transporter activity in hepatocellular carcinoma. World J Gastroenterol 2014; 20(33): 11780-11787 [PMID: 25206282 DOI: 10.3748/wjg.v20.i33.11780] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
38 Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl. 2007;13:807-813. [PMID: 17539001 DOI: 10.1002/lt.21054] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
39 Yang C, Fu R, Zhuang Z, Wang S. Studies on the biological functions of CPS1 in AFB1 induced hepatocarcinogenesis. Gene 2016;591:255-61. [PMID: 27425868 DOI: 10.1016/j.gene.2016.07.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
40 Xu Z, Wang F, Fan F, Gu Y, Shan N, Meng X, Cheng S, Liu Y, Wang C, Song Y, Xu R. Quantitative Proteomics Reveals That the Inhibition of Na + /K + -ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells. J Proteome Res 2015;14:4594-602. [DOI: 10.1021/acs.jproteome.5b00724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
41 Gurtsevitch VE. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc). 2008;73:504-513. [PMID: 18605975 DOI: 10.1134/s0006297908050039] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
42 Orvisky E, Drake SK, Martin BM, Abdel-Hamid M, Ressom HW, Varghese RS, An Y, Saha D, Hortin GL, Loffredo CA. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics. 2006;6:2895-2902. [PMID: 16586431 DOI: 10.1002/pmic.200500443] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 6.4] [Reference Citation Analysis]
43 Chingkoe CM, Chang SD, Legiehn GM, Weiss A. Hepatic artery pseudoaneurysms arising from within a hepatocellular carcinoma. Br J Radiol 2010;83:e252-4. [PMID: 21088082 DOI: 10.1259/bjr/55365425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Chen HY, Tang NH, Li XJ, Zhang SJ, Chen ZX, Wang XZ. Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells. World J Gastroenterol 2004; 10(7): 959-964 [PMID: 15052674 DOI: 10.3748/wjg.v10.i7.959] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
45 Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355-374. [PMID: 15190522 DOI: 10.1016/j.semarthrit.2003.10.001] [Cited by in Crossref: 327] [Cited by in F6Publishing: 242] [Article Influence: 18.2] [Reference Citation Analysis]
46 Sun M, Cui H, Liang M, Wang W, Wang Y, Liu X, Liu S, Cao L. Perceived dietary salt intake and the risk of primary liver cancer: a population-based prospective study. J Hum Nutr Diet 2020;33:833-40. [PMID: 32548912 DOI: 10.1111/jhn.12761] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Cervello M, Bachvarov D, Lampiasi N, Cusimano A, Azzolina A, McCubrey JA, Montalto G. Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle. 2012;11:2843-2855. [PMID: 22801548 DOI: 10.4161/cc.21193] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 8.5] [Reference Citation Analysis]
48 Mansoor OD, Salama P. Should hepatitis B vaccine be used for infants? Expert Rev Vaccines. 2007;6:29-33. [PMID: 17280476 DOI: 10.1586/14760584.6.1.29] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
49 Wang S, Xiang C, Mou L, Yang Y, Zhong R, Wang L, Sun C, Qin Z, Yang J, Qian J, Zhao Y, Wang Y, Pan X, Qie J, Jiang Y, Wang X, Yang Y, Zhou W, Miao X, He F, Jin L, Wang H. Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERα transcriptional program and may have undergone natural selection. Carcinogenesis 2020;41:146-58. [DOI: 10.1093/carcin/bgz136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
50 Chen X, Liu L, Pan X. Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report. Oncol Lett 2015;9:2495-8. [PMID: 26137096 DOI: 10.3892/ol.2015.3115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Cho LY, Yang JJ, Ko KP, Park B, Shin A, Lim MK, Oh JK, Park S, Kim YJ, Shin HR. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. Int J Cancer. 2011;128:176-184. [PMID: 20232388 DOI: 10.1002/ijc.25321] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 5.6] [Reference Citation Analysis]
52 Nakae D, Uematsu F, Kishida H, Kusuoka O, Katsuda S, Yoshida M, Takahashi M, Maekawa A, Denda A, Konishi Y, Kotake Y, Floyd RA. Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, l-amino acid-defined diet. Cancer Letters 2004;206:1-13. [DOI: 10.1016/j.canlet.2003.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
53 Sasaki Y. Insulin resistance and hepatocarcinogenesis. Clin J Gastroenterol 2010;3:271-8. [PMID: 26190483 DOI: 10.1007/s12328-010-0177-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
54 Wu HC, Santella R. The role of aflatoxins in hepatocellular carcinoma. Hepat Mon. 2012;12:e7238. [PMID: 23162603 DOI: 10.5812/hepatmon.7238] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
55 Ogawa K. Molecular pathology of early stage chemically induced hepatocarcinogenesis. Pathol Int. 2009;59:605-622. [PMID: 19712128 DOI: 10.1111/j.1440-1827.2009.02416.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
56 Wang L, Rasul A, Liu Z, Pan Y, Wang W, Li J, Li X. The Loss of Masculine With Declined Serum DHT Is Associated With High Risk of Hepatocellular Carcinoma in Chinese Men. Front Endocrinol (Lausanne) 2020;11:362. [PMID: 32695068 DOI: 10.3389/fendo.2020.00362] [Reference Citation Analysis]
57 Jeong SO, Kim EB, Jeong SW, Jang JY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim YJ, Goo DE, Park SY. Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma. Gut Liver 2017;11:409-16. [PMID: 28208001 DOI: 10.5009/gnl16001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
58 Demir M, Grünewald F, Lang S, Schramm C, Bowe A, Mück V, Kütting F, Goeser T, Steffen HM. Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Medicine (Baltimore) 2016;95:e4602. [PMID: 27661015 DOI: 10.1097/MD.0000000000004602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
59 Robaeys G, Bielen R, Azar DG, Razavi H, Nevens F. Global genotype distribution of hepatitis C viral infection among people who inject drugs. J Hepatol. 2016;65:1094-1103. [PMID: 27520879 DOI: 10.1016/j.jhep.2016.07.042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
60 Hu X, Jiang J, Ni C, Xu Q, Ye S, Wu J, Ge F, Han Y, Mo Y, Huang D, Yang L. HBV Integration-mediated Cell Apoptosis in HepG2.2.15. J Cancer 2019;10:4142-50. [PMID: 31417659 DOI: 10.7150/jca.30493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
61 Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-107. [DOI: 10.1038/sj.onc.1206557] [Cited by in Crossref: 350] [Cited by in F6Publishing: 332] [Article Influence: 18.4] [Reference Citation Analysis]
62 Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, Finegold M, Grompe M. Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell 2008;14:59-67. [PMID: 18598944 DOI: 10.1016/j.ccr.2008.05.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
63 Ayub A, Ashfaq UA, Haque A. HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int. 2013;2013:810461. [PMID: 23991421 DOI: 10.1155/2013/810461] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
64 Saad-Hussein A, Taha MM, Beshir S, Shahy EM, Shaheen W, Elhamshary M. Carcinogenic effects of aflatoxin B1 among wheat handlers. Int J Occup Environ Health. 2014;20:215-219. [PMID: 25000109 DOI: 10.1179/2049396714y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Moussa MM, Helal NS, Youssef MM. Significance of pSmad2/3 and Smad4 in hepatitis C virus-related liver fibrosis and hepatocellular carcinoma. APMIS 2018;126:477-85. [PMID: 29924446 DOI: 10.1111/apm.12844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J Virol 2012;86:7256-67. [PMID: 22532692 DOI: 10.1128/JVI.07222-11] [Cited by in Crossref: 122] [Cited by in F6Publishing: 83] [Article Influence: 12.2] [Reference Citation Analysis]
67 Xiong J, Yao YC, Zi XY, Li JX, Wang XM, Ye XT, Zhao SM, Yan YB, Yu HY, Hu YP. Expression of hepatitis B virus X protein in transgenic mice. World J Gastroenterol 2003; 9(1): 112-116 [PMID: 12508363 DOI: 10.3748/wjg.v9.i1.112] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
68 Jiménez-Sousa MÁ, Almansa R, de la Fuente C, Caro-Patón A, Ruiz L, Sánchez-Antolín G, González JM, Aller R, Alcaide N, Largo P, Ortiz de Lejarazu R, Bermejo-Martín JF. [Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients]. Enferm Infecc Microbiol Clin 2011;29:573-80. [PMID: 21722999 DOI: 10.1016/j.eimc.2011.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
69 Stuart K. Chemoembolization in the Management of Liver Tumors. The Oncologist 2003;8:425-37. [DOI: 10.1634/theoncologist.8-5-425] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
70 Sun M, Wang W, Liu X, Wang Y, Cui H, Liu S, Cao L. Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study. Medicine (Baltimore) 2021;100:e25746. [PMID: 33950959 DOI: 10.1097/MD.0000000000025746] [Reference Citation Analysis]
71 Iwata T, Inoue K, Nishiyama N, Nagano K, Izumi N, Mizuguchi S, Morita R, Tsukioka T, Suehiro S. Long-Term Outcome of Surgical Treatment for Non-Small Cell Lung Cancer With Comorbid Liver Cirrhosis. The Annals of Thoracic Surgery 2007;84:1810-7. [DOI: 10.1016/j.athoracsur.2007.07.030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
72 Scartozzi M, Baroni GS, Faloppi L, Paolo MD, Pierantoni C, Candelari R, Berardi R, Antognoli S, Mincarelli C, Risaliti A. Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. J Exp Clin Cancer Res. 2010;29:164. [PMID: 21159184 DOI: 10.1186/1756-9966-29-164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
73 Goldman R, Ressom HW, Abdel-Hamid M, Goldman L, Wang A, Varghese RS, An Y, Loffredo CA, Drake SK, Eissa SA. Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum. Carcinogenesis. 2007;28:2149-2153. [PMID: 17724376 DOI: 10.1093/carcin/bgm177] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
74 Tarocchi M, Polvani S, Marroncini G, Galli A. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 2014; 20(33): 11630-11640 [PMID: 25206269 DOI: 10.3748/wjg.v20.i33.11630] [Cited by in CrossRef: 101] [Cited by in F6Publishing: 87] [Article Influence: 12.6] [Reference Citation Analysis]
75 Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm 2006;2006:78380. [PMID: 17047295 DOI: 10.1155/MI/2006/78380] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
76 Gunzerath L, Faden V, Zakhari S, Warren K. National Institute on Alcohol Abuse and Alcoholism Report on Moderate Drinking. Alcoholism: Clinical and Experimental Research 2004;28:829-47. [DOI: 10.1097/01.alc.0000128382.79375.b6] [Cited by in Crossref: 184] [Cited by in F6Publishing: 75] [Article Influence: 11.5] [Reference Citation Analysis]
77 Shahera U, Munshi S, Jahan M, Nessa A, Alam S, Tabassum S. IP-10, p53, and Foxp3 Expression in Hepatocytes of Chronic Hepatitis B Patients with Cirrhosis and Hepatocellular Carcinoma. Euroasian J Hepatogastroenterol 2016;6:149-53. [PMID: 29201748 DOI: 10.5005/jp-journals-10018-1188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
78 Wang J, Jiang D, Zhang H, Lv S, Rao H, Fei R, Wei L. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2. Proteomics 2009;9:1672-82. [PMID: 19242931 DOI: 10.1002/pmic.200800621] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
79 Shirabe K, Toshima T, Taketomi A, Taguchi K, Yoshizumi T, Uchiyama H, Harimoto N, Kajiyama K, Egashira A, Maehara Y. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Liver Int. 2011;31:1366-1372. [PMID: 21745313 DOI: 10.1111/j.1478-3231.2011.02572.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
80 Page JM, Harrison SA. NASH and HCC. Clin Liver Dis. 2009;13:631-647. [PMID: 19818310 DOI: 10.1016/j.cld.2009.07.007] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 6.7] [Reference Citation Analysis]
81 Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol 2017; 23(18): 3228-3239 [PMID: 28566882 DOI: 10.3748/wjg.v23.i18.3228] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
82 Balasubramanian S, Kowdley KV. Effect of Alcohol on Viral Hepatitis and Other Forms of Liver Dysfunction. Clinics in Liver Disease 2005;9:83-101. [DOI: 10.1016/j.cld.2004.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
83 Jolly PE, Jiang Y, Ellis WO, Awuah RT, Appawu J, Nnedu O, Stiles JK, Wang J, Adjei O, Jolly CM, Williams JH. Association between aflatoxin exposure and health characteristics, liver function, hepatitis and malaria infections in Ghanaians. Journal of Nutritional & Environmental Medicine 2009;16:242-57. [DOI: 10.1080/13590840701703918] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
84 Opio P, Photchanachai S. Modified atmosphere influences aflatoxin B1 contamination and quality of peanut (Arachis hypogaea L.) kernels cv. Khon Kaen 84-8. Journal of Stored Products Research 2018;78:67-73. [DOI: 10.1016/j.jspr.2018.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
85 Wu YJ, Neoh CA, Tsao CY, Su JH, Li HH. Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways. Int J Mol Sci 2015;16:16469-82. [PMID: 26204832 DOI: 10.3390/ijms160716469] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
86 Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007; 13(1): 74-81 [PMID: 17206756 DOI: 10.3748/wjg.v13.i1.74] [Cited by in CrossRef: 170] [Cited by in F6Publishing: 167] [Article Influence: 11.3] [Reference Citation Analysis]
87 Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006;1089:228-236. [PMID: 17261770 DOI: 10.1196/annals.1386.044] [Cited by in Crossref: 176] [Cited by in F6Publishing: 147] [Article Influence: 11.7] [Reference Citation Analysis]
88 Lavi O, Skinner J, Gottesman MM. Network features suggest new hepatocellular carcinoma treatment strategies. BMC Syst Biol. 2014;8:88. [PMID: 25070212 DOI: 10.1186/s12918-014-0088-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
89 El-Kawy OA, Talaat HM. Preparation, characterization and evaluation of (186) Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma. J Labelled Comp Radiopharm 2016;59:72-7. [PMID: 26725469 DOI: 10.1002/jlcr.3368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
90 Caruana SR, Kelly HA, De Silva SL, Chea L, Nuon S, Saykao P, Bak N, Biggs BA. Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region. Aust N Z J Public Health. 2005;29:64-68. [PMID: 15782875 DOI: 10.1111/j.1467-842x.2005.tb00751.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
91 Cervello M, Bachvarov D, Cusimano A, Sardina F, Azzolina A, Lampiasi N, Giannitrapani L, Mccubrey JA, Montalto G. COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. OMICS: A Journal of Integrative Biology 2011;15:383-92. [DOI: 10.1089/omi.2010.0092] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
92 Tang J, Sharma R, Lamerato L, Sheehan M, Krajenta R, Gordon SC. Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma? J Clin Gastroenterol 2014;48:729-33. [PMID: 24618505 DOI: 10.1097/MCG.0000000000000111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
93 Allen J, Venook A. Hepatocellular carcinoma: epidemic and treatment. Curr Oncol Rep 2004;6:177-83. [PMID: 15066228 DOI: 10.1007/s11912-004-0047-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
94 Hu Z, Li Z, Xiang J, Zhou J, Yan S, Wu J, Zhou L, Zheng S. Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era: impact of hepatitis C and advanced status. Dig Dis Sci 2014;59:3062-72. [PMID: 25008426 DOI: 10.1007/s10620-014-3266-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Rasi G, Pierimarchi P, Sinibaldi Vallebona P, Colella F, Garaci E. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. International Immunopharmacology 2003;3:1169-76. [DOI: 10.1016/s1567-5769(03)00012-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
96 Tang A, Abukasm K, Moura Cunha G, Song B, Wang J, Wagner M, Dietrich CF, Brancatelli G, Ueda K, Choi J, Aguirre D, Sirlin CB. Imaging of hepatocellular carcinoma: a pilot international survey. Abdom Radiol 2021;46:205-15. [DOI: 10.1007/s00261-020-02598-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Cai RL, Meng W, Lu HY, Lin WY, Jiang F, Shen FM. Segregation analysis of hepatocellular carcinoma in a moderately high-incidence area of East China. World J Gastroenterol 2003; 9(11): 2428-2432 [PMID: 14606070 DOI: 10.3748/wjg.v9.i11.2428] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
98 Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, Loffredo CA, Abdel-Hamid M, Gouda I, Ezzat S, Kyselova Z. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res. 2009;15:1808-1813. [PMID: 19223512 DOI: 10.1158/1078-0432.ccr-07-5261] [Cited by in Crossref: 108] [Cited by in F6Publishing: 66] [Article Influence: 8.3] [Reference Citation Analysis]
99 Wang Q, Liu TT, Fu Y, Wang K, Yang XG. Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species. J Biol Inorg Chem 2010;15:1087-97. [PMID: 20443032 DOI: 10.1007/s00775-010-0668-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
100 Nozaki R, Murata S, Nowatari T, Maruyama T, Ikeda N, Kawasaki T, Fukunaga K, Ohkohchi N. Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin therapy for liver disease safe or not? Hepatol Res. 2013;43:610-620. [PMID: 23157389 DOI: 10.1111/hepr.12006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
101 D’Alessandro N, Poma P, Montalto G. Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? World J Gastroenterol 2007; 13(14): 2037-2043 [PMID: 17465444 DOI: 10.3748/wjg.v13.i14.2037] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
102 Ju H, Shim Y, Arumugam P, Song JM. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1. Toxicol Lett 2016;243:31-9. [PMID: 26739636 DOI: 10.1016/j.toxlet.2015.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
103 Palliyaguru DL, Wu F. Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2013;30:534-40. [PMID: 23281740 DOI: 10.1080/19440049.2012.751630] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
104 Wang P, Guo QS, Wang ZW, Qian HX. HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway. Mol Cell Biochem. 2013;372:161-168. [PMID: 23001846 DOI: 10.1007/s11010-012-1457-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
105 Van Thiel DH, Yong S, Li SD, Kennedy M, Brems J. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods. Liver Transpl 2004;10:631-7. [PMID: 15108254 DOI: 10.1002/lt.20120] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
106 Seufi AM, Ibrahim SS, Elmaghraby TK, Hafez EE. Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J Exp Clin Cancer Res. 2009;28:80. [PMID: 19519916 DOI: 10.1186/1756-9966-28-80] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 6.2] [Reference Citation Analysis]
107 Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J Viral Hepat. 2010;17 Suppl 1:34-43. [PMID: 20586932 DOI: 10.1111/j.1365-2893.2010.01269.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
108 Yuan Z, Liang Z, Yi J, Chen X, Li R, Wu J, Sun Z. Koumine Promotes ROS Production to Suppress Hepatocellular Carcinoma Cell Proliferation Via NF-κB and ERK/p38 MAPK Signaling. Biomolecules 2019;9:E559. [PMID: 31581704 DOI: 10.3390/biom9100559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
109 Yao KF, Ma M, Ding GY, Li ZM, Chen HL, Han B, Chen Q, Jiang XQ, Wang LS. Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI. Oncotarget 2017;8:72959-71. [PMID: 29069840 DOI: 10.18632/oncotarget.20127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
110 Li Z, Gao Z, Xiang J, Zhou J, Yan S, Hu Z. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: The impact of pre-existing diabetes mellitus. Liver Int 2019;39:361-70. [PMID: 30276959 DOI: 10.1111/liv.13982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
111 Ruggieri A, Barbati C, Malorni W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer. 2010;127:499-504. [PMID: 20201099 DOI: 10.1002/ijc.25298] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
112 Mboto CI, Davies-Russell A, Fielder M, Jewell AP. Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C. Int Semin Surg Oncol 2005;2:20. [PMID: 16202160 DOI: 10.1186/1477-7800-2-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
113 Keiser O, Giudici F, Müllhaupt B, Junker C, Dufour J-, Moradpour D, Bruggmann P, Terziroli B, Semela D, Brezzi M, Bertisch B, Estill J, Negro F, Spoerri A; the Swiss Hepatitis C Cohort Study and the Swiss National Cohort. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat 2018;25:152-60. [DOI: 10.1111/jvh.12803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
114 Liu Z, Dai X, Wang T, Zhang C, Zhang W, Zhang W, Zhang Q, Wu K, Liu F, Liu Y, Wu J. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. Cancer Lett 2017;400:149-60. [PMID: 28455240 DOI: 10.1016/j.canlet.2017.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
115 Chang JM, Chung JW, Jae HJ, Eh H, Son KR, Lee KC, Park JH. Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model. Acad Radiol 2007;14:85-92. [PMID: 17178370 DOI: 10.1016/j.acra.2006.09.059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
116 Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15 Suppl 4:14-22. [PMID: 21115577 DOI: 10.1634/theoncologist.2010-s4-14] [Cited by in Crossref: 293] [Cited by in F6Publishing: 161] [Article Influence: 26.6] [Reference Citation Analysis]
117 Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver. 2016;10:332-339. [PMID: 27114433 DOI: 10.5009/gnl15257] [Cited by in Crossref: 225] [Cited by in F6Publishing: 255] [Article Influence: 45.0] [Reference Citation Analysis]
118 Herrera LA, Benítez-Bribiesca L, Mohar A, Ostrosky-Wegman P. Role of infectious diseases in human carcinogenesis. Environ Mol Mutagen 2005;45:284-303. [PMID: 15744742 DOI: 10.1002/em.20122] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
119 Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019;9:27-33. [PMID: 31988864 DOI: 10.5005/jp-journals-10018-1292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Liu M, Xu M, Lee JK. The Acidity and Proton Affinity of the Damaged Base 1, N6 -Ethenoadenine in the Gas Phase versus in Solution: Intrinsic Reactivity and Biological Implications. J Org Chem 2008;73:5907-14. [DOI: 10.1021/jo800891c] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
121 Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health. 2009;9:34. [PMID: 19161623 DOI: 10.1186/1471-2458-9-34] [Cited by in Crossref: 151] [Cited by in F6Publishing: 137] [Article Influence: 11.6] [Reference Citation Analysis]
122 El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol Invest. 2008;37:661-674. [PMID: 18821214 DOI: 10.1080/08820130802111605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
123 Pei S, Zhang Y, Xu H, Chen X, Chen S. Inhibition of the Replication of Hepatitis B Virus in Vitro by Pu-erh Tea Extracts. J Agric Food Chem 2011;59:9927-34. [DOI: 10.1021/jf202376u] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
124 Chen CY, Zhong JH, Liu JL. Retrobulbar metastasis and intracranial invasion from postoperative hepatocellular carcinoma: A case report and review of the literature. Oncol Lett 2015;9:721-6. [PMID: 25624898 DOI: 10.3892/ol.2014.2733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Saalim M, Resham S, Manzoor S, Ahmad H, Bangash TA, Latif A, Jaleel S. IL-22 in hepatocyte's survival of Pakistani patients with end stage liver disease: an insight into IL 22 mediated hepato-regenerative pathway. Mol Biol Rep 2019;46:1127-38. [PMID: 30603953 DOI: 10.1007/s11033-018-04573-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
126 Wu H, Zhao W, Zhang J, Han J, Liu S. Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma. BMC Gastroenterol 2018;18:174. [PMID: 30419830 DOI: 10.1186/s12876-018-0899-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Notarbartolo M, Giannitrapani L, Vivona N, Poma P, Labbozzetta M, Florena AM, Porcasi R, Muggeo VM, Sandonato L, Cervello M. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. OMICS. 2011;15:267-272. [PMID: 21332389 DOI: 10.1089/omi.2010.0096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
128 Kiyici M, Yilmaz M, Akyildiz M, Arikan C, Aydin U, Sigirli D, Nart D, Yilmaz F, Ozacar T, Karasu Z, Kilic M. Association Between Hepatitis B and Hepatocellular Carcinoma Recurrence in Patients Undergoing Liver Transplantation. Transplantation Proceedings 2008;40:1511-7. [DOI: 10.1016/j.transproceed.2008.03.156] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
129 Ploss A, Evans MJ. Hepatitis C virus host cell entry. Curr Opin Virol. 2012;2:14-19. [PMID: 22440961 DOI: 10.1016/j.coviro.2011.12.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
130 Kurokawa T, Zheng YW, Ohkohchi N. Novel functions of platelets in the liver. J Gastroenterol Hepatol. 2016;31:745-751. [PMID: 26632220 DOI: 10.1111/jgh.13244] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
131 Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. J Virol 2010;84:6987-94. [PMID: 20463075 DOI: 10.1128/JVI.00196-10] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
132 Akbar HO, Al Ghamdi A, Qattan F, Fallatah HI, Al Rumani M. Chronic hepatitis C in saudi arabia: three years local experience in a university hospital. Hepat Mon 2012;12:e6178. [PMID: 23087760 DOI: 10.5812/hepatmon.6178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
133 Xiong XF, Liu ZH, Liu WD, Ma NF, Shen Y. Application of virtual touch tissue quantification to diagnose liver fibrosis in mice. Shijie Huaren Xiaohua Zazhi 2014; 22(7): 963-968 [DOI: 10.11569/wcjd.v22.i7.963] [Reference Citation Analysis]
134 Xiao J, Zhao Y, Varghese RS, Zhou B, Di Poto C, Zhang L, Tadesse MG, Ziada DH, Shetty K, Ressom HW. Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis. Cancer Epidemiol Biomarkers Prev 2014;23:64-72. [PMID: 24186894 DOI: 10.1158/1055-9965.EPI-13-0327] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
135 Urano S, Ohara T, Noma K, Katsube R, Ninomiya T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F. Iron depletion enhances the effect of sorafenib in hepatocarcinoma. Cancer Biol Ther. 2016;17:648-656. [PMID: 27089255 DOI: 10.1080/15384047.2016.1177677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
136 Shao X, Liu Y, Huang H, Zhuang L, Luo T, Huang H, Ge X. Down-regulation of G protein-coupled receptor 137 by RNA interference inhibits cell growth of two hepatoma cell lines. Cell Biol Int. 2015;39:418-426. [PMID: 25490967 DOI: 10.1002/cbin.10412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
137 Lawlor DA, Sterne JAC, Tynelius P, Davey Smith G, Rasmussen F. Association of Childhood Socioeconomic Position with Cause-specific Mortality in a Prospective Record Linkage Study of 1,839,384 Individuals. American Journal of Epidemiology 2006;164:907-15. [DOI: 10.1093/aje/kwj319] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 5.6] [Reference Citation Analysis]
138 Coviello E, Caputi G, Martinelli D, Germinario CA, Prato R. Mortality trends for primary liver cancer in Puglia, Italy. European Journal of Cancer Prevention 2010;19:417-23. [DOI: 10.1097/cej.0b013e32833ad36e] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
139 Tsuchishima M, George J, Shiroeda H, Arisawa T, Takegami T, Tsutsumi M. Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult. Dig Dis Sci 2013;58:1923-33. [PMID: 23371017 DOI: 10.1007/s10620-013-2574-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
140 Zhao X, Yang Z, Li G, Li D, Zhao Y, Wu Y, Robson SC, He L, Xu Y, Miao R, Zhao H. The role and clinical implications of microRNAs in hepatocellular carcinoma. Sci China Life Sci 2012;55:906-19. [PMID: 23108868 DOI: 10.1007/s11427-012-4384-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
141 Hackl C, Schlitt HJ, Kirchner GI, Knoppke B, Loss M. Liver transplantation for malignancy: Current treatment strategies and future perspectives. World J Gastroenterol 2014; 20(18): 5331-5344 [PMID: 24833863 DOI: 10.3748/wjg.v20.i18.5331] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
142 Wu CS, Yen CJ, Chou RH, Li ST, Huang WC, Ren CT, Wu CY, Yu YL. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. PLoS One 2012;7:e39466. [PMID: 22808038 DOI: 10.1371/journal.pone.0039466] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
143 Tanwar S, Khan SA, Grover VPB, Gwilt C, Smith B, Brown A. Liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2009; 15(44): 5511-5516 [PMID: 19938188 DOI: 10.3748/wjg.15.5511] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
144 Saad-Hussein A, Taha MM, Beshir S, Shahy EM, Shaheen W, Elhamshary M. Carcinogenic effects of aflatoxin B1 among wheat handlers. Int J Occup Environ Health 2014;20:215-9. [PMID: 25000109 DOI: 10.1179/2049396714Y.0000000069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
145 Murakami A, Matsumoto K, Koshimizu K, Ohigashi H. Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-γ-induced IκB degradation in RAW264.7 macrophages. Cancer Letters 2003;195:17-25. [DOI: 10.1016/s0304-3835(03)00058-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
146 Marrero JA. Hepatocellular carcinoma: . Current Opinion in Gastroenterology 2003;19:243-9. [DOI: 10.1097/00001574-200305000-00007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
147 Çıkla-süzgün P, Kaushik-basu N, Basu A, Arora P, Talele TT, Durmaz I, Çetin-atalay R, Küçükgüzel Ş. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles. Journal of Enzyme Inhibition and Medicinal Chemistry 2015;30:778-85. [DOI: 10.3109/14756366.2014.971780] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
148 Park ER, Kim SB, Lee JS, Kim YH, Lee DH, Cho EH, Park SH, Han CJ, Kim BY, Choi DW, Yoo YD, Yu A, Lee JW, Jang JJ, Park YN, Suh KS, Lee KH. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. Cancer Med 2017;6:749-60. [PMID: 28332314 DOI: 10.1002/cam4.1042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
149 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14(27): 4300-4308 [PMID: 18666317 DOI: 10.3748/wjg.14.4300] [Cited by in CrossRef: 408] [Cited by in F6Publishing: 377] [Article Influence: 29.1] [Reference Citation Analysis]
150 Steelman LS, Stadelman KM, Chappell WH, Horn S, Bäsecke J, Cervello M, Nicoletti F, Libra M, Stivala F, Martelli AM, McCubrey JA. Akt as a therapeutic target in cancer. Expert Opin Ther Targets 2008;12:1139-65. [PMID: 18694380 DOI: 10.1517/14728222.12.9.1139] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 7.2] [Reference Citation Analysis]
151 Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, Zeiner GM, Evans MJ. HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol. 2011;85:12087-12092. [PMID: 21917968 DOI: 10.1128/jvi.05843-11] [Cited by in Crossref: 104] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
152 Czaja AJ. Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci. 2013;58:1459-1476. [PMID: 23306849 DOI: 10.1007/s10620-012-2525-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
153 Cervello M, Bachvarov D, Lampiasi N, Cusimano A, Azzolina A, McCubrey JA, Montalto G. Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. PLoS One 2013;8:e65569. [PMID: 23776502 DOI: 10.1371/journal.pone.0065569] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
154 Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 2014;3:353-67. [DOI: 10.1586/egh.09.35] [Cited by in Crossref: 197] [Cited by in F6Publishing: 194] [Article Influence: 24.6] [Reference Citation Analysis]
155 Chuu J, Liu JM, Tsou M, Huang C, Chen C, Wang H, Chen C. Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas. J Biomed Sci 2007;14:233-44. [DOI: 10.1007/s11373-006-9141-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
156 Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, Sperlongano P, Vincenzi B, Naviglio S, Prete SD. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis. 2011;2:e150. [PMID: 21525937 DOI: 10.1038/cddis.2011.34] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.9] [Reference Citation Analysis]
157 Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD. Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract 2012;18:335-42. [PMID: 21114800 DOI: 10.1111/j.1365-2753.2010.01599.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
158 El-Zayadi AR, Badran HM, Barakat EM, Attia MED, Shawky S, Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: A single center study over a decade. World J Gastroenterol 2005; 11(33): 5193-5198 [PMID: 16127751 DOI: 10.3748/wjg.v11.i33.5193] [Cited by in F6Publishing: 42] [Reference Citation Analysis]
159 Giacalone A, Montalto G, Giannitrapani L, Balasus D, Terranova A, Cervello M, Soresi M, Marasà L. Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-α, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma. OMICS: A Journal of Integrative Biology 2011;15:193-6. [DOI: 10.1089/omi.2010.0095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
160 Bedossa P, Paradis V. Hepatocellular Carcinoma. Practical Hepatic Pathology: A Diagnostic Approach. Elsevier; 2011. pp. 489-501. [DOI: 10.1016/b978-0-443-06803-4.00035-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
161 Osna NA, Eguchi A, Feldstein AE, Tsukamoto H, Dagur RS, Ganesan M, New-aaron M, Arumugam MK, Chava S, Ribeiro M, Szabo G, Mueller S, Wang S, Chen C, Weinman SA, Kharbanda KK. Cell-to-Cell Communications in Alcohol-Associated Liver Disease. Front Physiol 2022;13:831004. [DOI: 10.3389/fphys.2022.831004] [Reference Citation Analysis]
162 Lee S, Kim S. Gene regulations in HBV-related liver cirrhosis closely correlate with disease severity. J Biochem Mol Biol 2007;40:814-24. [PMID: 17927917 DOI: 10.5483/bmbrep.2007.40.5.814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
163 Thiesen AL. Hepatocellular Carcinoma in Adults. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 39-54. [DOI: 10.36255/exonpublications.livercancer.2021.ch2] [Reference Citation Analysis]
164 Cervello M, McCubrey JA, Cusimano A, Lampiasi N, Azzolina A, Montalto G. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012;3:236-60. [PMID: 22470194 DOI: 10.18632/oncotarget.466] [Cited by in Crossref: 123] [Cited by in F6Publishing: 122] [Article Influence: 12.3] [Reference Citation Analysis]
165 Lin J, Shen A, Chen H, Liao J, Xu T, Liu L, Lin J, Peng J. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 2014;14:729. [PMID: 25266147 DOI: 10.1186/1471-2407-14-729] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
166 Giannios P, Toutouzas KG, Matiatou M, Stasinos K, Konstadoulakis MM, Zografos GC, Moutzouris K. Visible to near-infrared refractive properties of freshly-excised human-liver tissues: marking hepatic malignancies. Sci Rep 2016;6:27910. [PMID: 27297034 DOI: 10.1038/srep27910] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
167 Kurokawa Y, Matoba R, Takemasa I, Nakamori S, Tsujie M, Nagano H, Dono K, Umeshita K, Sakon M, Ueno N. Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J Hepatol. 2003;39:1004-1012. [PMID: 14642619 DOI: 10.1016/s0168-8278(03)00473-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
168 Faggioli F, Palagano E, Di Tommaso L, Donadon M, Marrella V, Recordati C, Mantero S, Villa A, Vezzoni P, Cassani B. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury. Hepatology 2018;67:1970-85. [PMID: 29105104 DOI: 10.1002/hep.29636] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
169 Cheng CW, Leong KW, Tse E. Understanding the role of PIN1 in hepatocellular carcinoma. World J Gastroenterol 2016; 22(45): 9921-9932 [PMID: 28018099 DOI: 10.3748/wjg.v22.i45.9921] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
170 Chan KM, Wu TH, Wu TJ, Chou HS, Yu MC, Lee WC. Bioinformatics microarray analysis and identification of gene expression profiles associated with cirrhotic liver. Kaohsiung J Med Sci 2016;32:165-76. [PMID: 27185598 DOI: 10.1016/j.kjms.2016.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
171 Cho IJ, Ki SH, Brooks C 3rd, Kim SG. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression. Xenobiotica 2009;39:182-92. [PMID: 19255944 DOI: 10.1080/00498250802549808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
172 Hamid AS, Tesfamariam IG, Zhang Y, Zhang ZG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncol Lett 2013;5:1087-92. [PMID: 23599745 DOI: 10.3892/ol.2013.1169] [Cited by in Crossref: 149] [Cited by in F6Publishing: 123] [Article Influence: 16.6] [Reference Citation Analysis]
173 Scartozzi M, Faloppi L, Bianconi M, Giampieri R, Maccaroni E, Bittoni A, Del Prete M, Loretelli C, Belvederesi L, Svegliati Baroni G. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PLoS One. 2012;7:e32653. [PMID: 22461886 DOI: 10.1371/journal.pone.0032653] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
174 Zhao X, Fu J, Xu A, Yu L, Zhu J, Dai R, Su B, Luo T, Li N, Qin W, Wang B, Jiang J, Li S, Chen Y, Wang H. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis 2015;6:e1751. [PMID: 25950481 DOI: 10.1038/cddis.2015.120] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
175 Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases 2005;5:558-67. [DOI: 10.1016/s1473-3099(05)70216-4] [Cited by in Crossref: 1868] [Cited by in F6Publishing: 851] [Article Influence: 109.9] [Reference Citation Analysis]
176 Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, Narbus CM, Parra Martín A, Evans MJ. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog. 2013;9:e1003244. [PMID: 23555257 DOI: 10.1371/journal.ppat.1003244] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
177 Tumino R, Frasca G, Palli D, Masala G, Tagliabue G, Evangelista A, Giurdanella MC, Vineis P, Veglia F, Celentano E, Galasso R, Cascone G. Cancer Incidence in Epic-Italy at First Follow-Up. Tumori 2003;89:656-64. [DOI: 10.1177/030089160308900609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
178 Zhao JY, Lin W, Zhuang QC, Zhong XY, Peng J, Hong ZF. Bear bile powder inhibits angiogenesis in vivo and in vitro. Chin J Integr Med 2015;21:369-75. [PMID: 25776838 DOI: 10.1007/s11655-015-2062-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
179 Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol 2006; 12(32): 5113-5121 [PMID: 16937518 DOI: 10.3748/wjg.v12.i32.5113] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
180 Hathout AS, Mohamed SR, El-nekeety AA, Hassan NS, Aly SE, Abdel-wahhab MA. Ability of Lactobacillus casei and Lactobacillus reuteri to protect against oxidative stress in rats fed aflatoxins-contaminated diet. Toxicon 2011;58:179-86. [DOI: 10.1016/j.toxicon.2011.05.015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
181 Han SS, Kelly SP, Li Y, Yang B, Nguyen M, So S, Rosenberg PS, Hsing AW. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. J Natl Cancer Inst 2019;111:550-6. [PMID: 30544184 DOI: 10.1093/jnci/djy180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
182 Zhao J, Chen Z, Lin W, Zhong X, Chen X, Peng J, Hong Z. Bear bile powder (熊胆粉) induces apoptosis of human hepatocellular carcinoma cells via mitochondrion-dependent pathway. Chin J Integr Med 2014;20:123-9. [DOI: 10.1007/s11655-013-1581-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
183 Yun EH, Lim MK, Oh JK, Park JH, Shin A, Sung J, Park EC. Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea. Br J Cancer. 2010;103:741-746. [PMID: 20648009 DOI: 10.1038/sj.bjc.6605803] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
184 Kurokawa T, Murata S, Zheng YW, Iwasaki K, Kohno K, Fukunaga K, Ohkohchi N. The Eltrombopag antitumor effect on hepatocellular carcinoma. Int J Oncol 2015;47:1696-702. [PMID: 26397763 DOI: 10.3892/ijo.2015.3180] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
185 Chen CY, Zhong JH, Liu JL. Retrobulbar metastasis and intracranial invasion from postoperative hepatocellular carcinoma: A case report and review of the literature. Oncol Lett. 2015;9:721-726. [PMID: 25624898 DOI: 10.3892/ol] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
186 Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol. 2005;100:1995-2004. [PMID: 16128944 DOI: 10.1111/j.1572-0241.2005.00229.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 5.9] [Reference Citation Analysis]
187 Mccubrey JA, Steelman LS, Abrams SL, Chappell WH, Russo S, Ove R, Milella M, Tafuri A, Lunghi P, Bonati A, Stivala F, Nicoletti F, Libra M, Martelli AM, Montalto G, Cervello M. Emerging Raf inhibitors. Expert Opinion on Emerging Drugs 2009;14:633-48. [DOI: 10.1517/14728210903232633] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
188 Tran-Dinh N, Kennedy I, Bui T, Carter D. Survey of Vietnamese peanuts, corn and soil for the presence of Aspergillus flavus and Aspergillus parasiticus. Mycopathologia 2009;168:257-68. [PMID: 19693687 DOI: 10.1007/s11046-009-9221-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
189 Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, Donia M, Fagone P, Malaponte G, Nicoletti F, Libra M, Milella M, Tafuri A, Bonati A, Bäsecke J, Cocco L, Evangelisti C, Martelli AM, Montalto G, Cervello M, McCubrey JA. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY) 2011;3:192-222. [PMID: 21422497 DOI: 10.18632/aging.100296] [Cited by in Crossref: 366] [Cited by in F6Publishing: 367] [Article Influence: 33.3] [Reference Citation Analysis]
190 Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore). 2004;83:176-187. [PMID: 15118544 DOI: 10.1097/01.md.0000126971.80227.a4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
191 Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med. 2011;9:171. [PMID: 21985599 DOI: 10.1186/1479-5876-9-171] [Cited by in Crossref: 143] [Cited by in F6Publishing: 134] [Article Influence: 13.0] [Reference Citation Analysis]